Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
22-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #41764
advertisement
Sung KR
20
Showing records 1 to 20 |
Display all abstracts from
Sung KR
95664
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Kim ML
International journal of molecular sciences
2021; 22:
96033
Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Sakata R
Seminars in Ophthalmology
2021; 0: 1-8
96102
Effect of Postoperative Trimming of the Tube Portion of Ahmed Glaucoma Valve on Corneal Endothelial Cell Loss
Lee KE
Journal of Glaucoma
2022; 31: 102-108
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Kim JM
International Journal of Ophthalmology
2021; 14: 1539-1547
95553
Implications of the Relationship Between Refractive Error and Biometry in the Pathogenesis of Primary Angle Closure
Shon K
Investigative Ophthalmology and Visual Science
2021; 62: 38
96102
Effect of Postoperative Trimming of the Tube Portion of Ahmed Glaucoma Valve on Corneal Endothelial Cell Loss
Sung KR
Journal of Glaucoma
2022; 31: 102-108
95553
Implications of the Relationship Between Refractive Error and Biometry in the Pathogenesis of Primary Angle Closure
Sung KR
Investigative Ophthalmology and Visual Science
2021; 62: 38
95664
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Sung KR
International journal of molecular sciences
2021; 22:
96033
Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Chang PY
Seminars in Ophthalmology
2021; 0: 1-8
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Sung KR; Lee JW
International Journal of Ophthalmology
2021; 14: 1539-1547
96102
Effect of Postoperative Trimming of the Tube Portion of Ahmed Glaucoma Valve on Corneal Endothelial Cell Loss
Shin JW
Journal of Glaucoma
2022; 31: 102-108
95553
Implications of the Relationship Between Refractive Error and Biometry in the Pathogenesis of Primary Angle Closure
Yoon JY
Investigative Ophthalmology and Visual Science
2021; 62: 38
95664
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Kwon J
International journal of molecular sciences
2021; 22:
96033
Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Sung KR; Kim TW
Seminars in Ophthalmology
2021; 0: 1-8
95664
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Choi GW
International journal of molecular sciences
2021; 22:
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Kyung H; Rho S
International Journal of Ophthalmology
2021; 14: 1539-1547
95664
Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
Shin JA
International journal of molecular sciences
2021; 22:
96033
Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Wang TH; Perera SA
Seminars in Ophthalmology
2021; 0: 1-8
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Kim CY
International Journal of Ophthalmology
2021; 14: 1539-1547
96033
Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need
Cantor LB
Seminars in Ophthalmology
2021; 0: 1-8
Issue
22-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement